Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses.
Identifieur interne : 002055 ( Ncbi/Curation ); précédent : 002054; suivant : 002056Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses.
Auteurs : Reina Yamaji [Suisse] ; Magdi D. Saad [Suisse] ; Charles T. Davis [États-Unis] ; David E. Swayne [États-Unis] ; Dayan Wang [République populaire de Chine] ; Frank Y K. Wong [Australie] ; John W. Mccauley [Royaume-Uni] ; J S Malik Peiris [République populaire de Chine] ; Richard J. Webby [États-Unis] ; Ron A M. Fouchier [Pays-Bas] ; Yoshihiro Kawaoka [Japon] ; Wenqing Zhang [Suisse]Source :
- Reviews in medical virology [ 1099-1654 ] ; 2020.
Abstract
The panzootic caused by A/goose/Guangdong/1/96-lineage highly pathogenic avian influenza (HPAI) A(H5) viruses has occurred in multiple waves since 1996. From 2013 onwards, clade 2.3.4.4 viruses of subtypes A(H5N2), A(H5N6), and A(H5N8) emerged to cause panzootic waves of unprecedented magnitude among avian species accompanied by severe losses to the poultry industry around the world. Clade 2.3.4.4 A(H5) viruses have expanded in distinct geographical and evolutionary pathways likely via long distance migratory bird dispersal onto several continents and by poultry trade among neighboring countries. Coupled with regional circulation, the viruses have evolved further by reassorting with local viruses. As of February 2019, there have been 23 cases of humans infected with clade 2.3.4.4 H5N6 viruses, 16 (70%) of which had fatal outcomes. To date, no HPAI A(H5) virus has caused sustainable human-to-human transmission. However, due to the lack of population immunity in humans and ongoing evolution of the virus, there is a continuing risk that clade 2.3.4.4 A(H5) viruses could cause an influenza pandemic if the ability to transmit efficiently among humans was gained. Therefore, multisectoral collaborations among the animal, environmental, and public health sectors are essential to conduct risk assessments and develop countermeasures to prevent disease and to control spread. In this article, we describe an assessment of the likelihood of clade 2.3.4.4 A(H5) viruses gaining human-to-human transmissibility and impact on human health should such human-to-human transmission occur. This structured analysis assessed properties of the virus, attributes of the human population, and ecology and epidemiology of these viruses in animal hosts.
DOI: 10.1002/rmv.2099
PubMed: 32135031
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000043
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000043
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000021
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002055
Links to Exploration step
pubmed:32135031Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses.</title>
<author><name sortKey="Yamaji, Reina" sort="Yamaji, Reina" uniqKey="Yamaji R" first="Reina" last="Yamaji">Reina Yamaji</name>
<affiliation wicri:level="1"><nlm:affiliation>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Saad, Magdi D" sort="Saad, Magdi D" uniqKey="Saad M" first="Magdi D" last="Saad">Magdi D. Saad</name>
<affiliation wicri:level="1"><nlm:affiliation>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Davis, Charles T" sort="Davis, Charles T" uniqKey="Davis C" first="Charles T" last="Davis">Charles T. Davis</name>
<affiliation wicri:level="2"><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Swayne, David E" sort="Swayne, David E" uniqKey="Swayne D" first="David E" last="Swayne">David E. Swayne</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Agriculture, OIE Collaborating Centre for Research on Emerging Avian Diseases, U.S. National Poultry Research Center, Agricultural Research Service, Athens, Georgia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Agriculture, OIE Collaborating Centre for Research on Emerging Avian Diseases, U.S. National Poultry Research Center, Agricultural Research Service, Athens, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wang, Dayan" sort="Wang, Dayan" uniqKey="Wang D" first="Dayan" last="Wang">Dayan Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>National Institute for Viral Disease Control and Prevention, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Institute for Viral Disease Control and Prevention</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wong, Frank Y K" sort="Wong, Frank Y K" uniqKey="Wong F" first="Frank Y K" last="Wong">Frank Y K. Wong</name>
<affiliation wicri:level="1"><nlm:affiliation>CSIRO Australian Animal Health Laboratory, Geelong, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>CSIRO Australian Animal Health Laboratory, Geelong</wicri:regionArea>
<wicri:noRegion>Geelong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mccauley, John W" sort="Mccauley, John W" uniqKey="Mccauley J" first="John W" last="Mccauley">John W. Mccauley</name>
<affiliation wicri:level="3"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Peiris, J S Malik" sort="Peiris, J S Malik" uniqKey="Peiris J" first="J S Malik" last="Peiris">J S Malik Peiris</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region</wicri:regionArea>
<wicri:noRegion>Hong Kong Special Administrative Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J" last="Webby">Richard J. Webby</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fouchier, Ron A M" sort="Fouchier, Ron A M" uniqKey="Fouchier R" first="Ron A M" last="Fouchier">Ron A M. Fouchier</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kawaoka, Yoshihiro" sort="Kawaoka, Yoshihiro" uniqKey="Kawaoka Y" first="Yoshihiro" last="Kawaoka">Yoshihiro Kawaoka</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<orgName type="university">Université de Tokyo</orgName>
<placeName><settlement type="city">Madison (Wisconsin)</settlement>
<region type="state">Wisconsin</region>
</placeName>
<orgName type="university" n="3">Université du Wisconsin à Madison</orgName>
</affiliation>
</author>
<author><name sortKey="Zhang, Wenqing" sort="Zhang, Wenqing" uniqKey="Zhang W" first="Wenqing" last="Zhang">Wenqing Zhang</name>
<affiliation wicri:level="1"><nlm:affiliation>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32135031</idno>
<idno type="pmid">32135031</idno>
<idno type="doi">10.1002/rmv.2099</idno>
<idno type="wicri:Area/PubMed/Corpus">000043</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000043</idno>
<idno type="wicri:Area/PubMed/Curation">000043</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000043</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000021</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000021</idno>
<idno type="wicri:Area/Ncbi/Merge">002055</idno>
<idno type="wicri:Area/Ncbi/Curation">002055</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses.</title>
<author><name sortKey="Yamaji, Reina" sort="Yamaji, Reina" uniqKey="Yamaji R" first="Reina" last="Yamaji">Reina Yamaji</name>
<affiliation wicri:level="1"><nlm:affiliation>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Saad, Magdi D" sort="Saad, Magdi D" uniqKey="Saad M" first="Magdi D" last="Saad">Magdi D. Saad</name>
<affiliation wicri:level="1"><nlm:affiliation>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Davis, Charles T" sort="Davis, Charles T" uniqKey="Davis C" first="Charles T" last="Davis">Charles T. Davis</name>
<affiliation wicri:level="2"><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Swayne, David E" sort="Swayne, David E" uniqKey="Swayne D" first="David E" last="Swayne">David E. Swayne</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Agriculture, OIE Collaborating Centre for Research on Emerging Avian Diseases, U.S. National Poultry Research Center, Agricultural Research Service, Athens, Georgia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Agriculture, OIE Collaborating Centre for Research on Emerging Avian Diseases, U.S. National Poultry Research Center, Agricultural Research Service, Athens, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wang, Dayan" sort="Wang, Dayan" uniqKey="Wang D" first="Dayan" last="Wang">Dayan Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>National Institute for Viral Disease Control and Prevention, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Institute for Viral Disease Control and Prevention</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wong, Frank Y K" sort="Wong, Frank Y K" uniqKey="Wong F" first="Frank Y K" last="Wong">Frank Y K. Wong</name>
<affiliation wicri:level="1"><nlm:affiliation>CSIRO Australian Animal Health Laboratory, Geelong, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>CSIRO Australian Animal Health Laboratory, Geelong</wicri:regionArea>
<wicri:noRegion>Geelong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mccauley, John W" sort="Mccauley, John W" uniqKey="Mccauley J" first="John W" last="Mccauley">John W. Mccauley</name>
<affiliation wicri:level="3"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Peiris, J S Malik" sort="Peiris, J S Malik" uniqKey="Peiris J" first="J S Malik" last="Peiris">J S Malik Peiris</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region</wicri:regionArea>
<wicri:noRegion>Hong Kong Special Administrative Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J" last="Webby">Richard J. Webby</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fouchier, Ron A M" sort="Fouchier, Ron A M" uniqKey="Fouchier R" first="Ron A M" last="Fouchier">Ron A M. Fouchier</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kawaoka, Yoshihiro" sort="Kawaoka, Yoshihiro" uniqKey="Kawaoka Y" first="Yoshihiro" last="Kawaoka">Yoshihiro Kawaoka</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<orgName type="university">Université de Tokyo</orgName>
<placeName><settlement type="city">Madison (Wisconsin)</settlement>
<region type="state">Wisconsin</region>
</placeName>
<orgName type="university" n="3">Université du Wisconsin à Madison</orgName>
</affiliation>
</author>
<author><name sortKey="Zhang, Wenqing" sort="Zhang, Wenqing" uniqKey="Zhang W" first="Wenqing" last="Zhang">Wenqing Zhang</name>
<affiliation wicri:level="1"><nlm:affiliation>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Global Influenza Programme, Infectious Hazards Management, WHO Emergency Programme, WHO, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Reviews in medical virology</title>
<idno type="eISSN">1099-1654</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The panzootic caused by A/goose/Guangdong/1/96-lineage highly pathogenic avian influenza (HPAI) A(H5) viruses has occurred in multiple waves since 1996. From 2013 onwards, clade 2.3.4.4 viruses of subtypes A(H5N2), A(H5N6), and A(H5N8) emerged to cause panzootic waves of unprecedented magnitude among avian species accompanied by severe losses to the poultry industry around the world. Clade 2.3.4.4 A(H5) viruses have expanded in distinct geographical and evolutionary pathways likely via long distance migratory bird dispersal onto several continents and by poultry trade among neighboring countries. Coupled with regional circulation, the viruses have evolved further by reassorting with local viruses. As of February 2019, there have been 23 cases of humans infected with clade 2.3.4.4 H5N6 viruses, 16 (70%) of which had fatal outcomes. To date, no HPAI A(H5) virus has caused sustainable human-to-human transmission. However, due to the lack of population immunity in humans and ongoing evolution of the virus, there is a continuing risk that clade 2.3.4.4 A(H5) viruses could cause an influenza pandemic if the ability to transmit efficiently among humans was gained. Therefore, multisectoral collaborations among the animal, environmental, and public health sectors are essential to conduct risk assessments and develop countermeasures to prevent disease and to control spread. In this article, we describe an assessment of the likelihood of clade 2.3.4.4 A(H5) viruses gaining human-to-human transmissibility and impact on human health should such human-to-human transmission occur. This structured analysis assessed properties of the virus, attributes of the human population, and ecology and epidemiology of these viruses in animal hosts.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002055 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 002055 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:32135031 |texte= Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:32135031" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a PandemieGrippaleV1
![]() | This area was generated with Dilib version V0.6.34. | ![]() |